Restless legs syndrome (RLS) and periodic leg movements disorder (PLMD) are present in 5 percent and 11 percent of the population, respectively and can cause a severe sleep disruption; however, no animal model exhibits key aspects of the human syndrome. We hypothesize that the ventral mesopontine junction (VMPJ), including the rostroventral pons and the caudal part of the dopaminergic retrorubral nucleus and ventral tegmental area, plays a crucial role in the etiology of this disorder, as well as in REM sleep behavior disorder (RBD), which is present in 0.5 percent of the population. Our previous studies found that NMDA lesion of the VMPJ area produces periodic leg movement (PLM) in the decerebrate cat, and that this can be attenuated by glutamate injection into the medullary magnocellularis nucleus. This suggests that descending projections from the VMPJ are important in the control of muscle activity. Our pilot data in the intact freely moving cat indicates that 6-hydroxydopamine (6-OHDA) lesions of the dopaminergic neurons of the VMPJ elicit PLM's during slow wave sleep (SWS). The PLM's in SWS seen in the otherwise intact 6-OHDA lesioned cat resemble those seen in PLMD in humans. Our pilot data also suggest that NMDA lesions of the VMPJ cause PLM's during SWS, as well as an increase in tonic and phasic muscle activities during REM sleep and an increase in total sleep time. These effects duplicate the syndrome seen in RBD in humans. We hypothesize that VMPJ projections to the caudal brainstem regulate motor activity in SWS and REM sleep. We propose to investigate the role of the VMPJ in motor control across the sleep-wake cycle with cytotoxic lesion, anatomical, microinjection and dialysis techniques. In contrast to the well-established ascending midbrain dopaminergic mechanism of motor control via the basal ganglia, the role of the descending dopaminergic system in the control of motor activity has received little attention. This proposed work is of critical importance for the understanding of RLS/PLMD, RBD and other motor pathologies of sleep and for the design of therapeutic strategies to reverse these disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS042566-03
Application #
6930956
Study Section
Special Emphasis Panel (ZRG1-IFCN-3 (01))
Program Officer
Mitler, Merrill
Project Start
2003-09-01
Project End
2007-06-30
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
3
Fiscal Year
2005
Total Cost
$209,475
Indirect Cost
Name
University of California Los Angeles
Department
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Hsieh, Kung-Chiao; Nguyen, Darian; Siegel, Jerome M et al. (2013) New pathways and data on rapid eye movement sleep behaviour disorder in a rat model. Sleep Med 14:719-28
Lai, Yuan-Yang; Kodama, Tohru; Schenkel, Elizabeth et al. (2010) Behavioral response and transmitter release during atonia elicited by medial medullary stimulation. J Neurophysiol 104:2024-33
Lai, Y-Y; Hsieh, K-C; Nguyen, D et al. (2008) Neurotoxic lesions at the ventral mesopontine junction change sleep time and muscle activity during sleep: an animal model of motor disorders in sleep. Neuroscience 154:431-43
Taepavarapruk, N; Taepavarapruk, P; John, J et al. (2008) State-dependent changes in glutamate, glycine, GABA, and dopamine levels in cat lumbar spinal cord. J Neurophysiol 100:598-608
Thannickal, Thomas C; Lai, Yuan-Yang; Siegel, Jerome M (2007) Hypocretin (orexin) cell loss in Parkinson's disease. Brain 130:1586-95